Your browser doesn't support javascript.
loading
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
Axelsson Raja, Anna; Wakimoto, Hiroko; DeLaughter, Daniel M; Reichart, Daniel; Gorham, Joshua; Conner, David A; Lun, Mingyue; Probst, Clemens K; Sakai, Norihiko; Knipe, Rachel S; Montesi, Sydney B; Shea, Barry; Adam, Leonard P; Leinwand, Leslie A; Wan, William; Choi, Esther Sue; Lindberg, Eric L; Patone, Giannino; Noseda, Michela; Hübner, Norbert; Seidman, Christine E; Tager, Andrew M; Seidman, J G; Ho, Carolyn Y.
Afiliación
  • Axelsson Raja A; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Wakimoto H; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
  • DeLaughter DM; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Reichart D; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Gorham J; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Conner DA; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Lun M; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Probst CK; Department of Genetics, Harvard Medical School, Boston, MA 02115.
  • Sakai N; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Knipe RS; Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Montesi SB; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Shea B; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Adam LP; Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Leinwand LA; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Wan W; Division of Nephrology, Kanazawa University, Kanazawa, 920-1192 Japan.
  • Choi ES; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Lindberg EL; Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Patone G; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Noseda M; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
  • Hübner N; Division of Pulmonary, Critical Care and Sleep Medicine, Albert Medical School of Brown University, Providence, RI 02903.
  • Seidman CE; Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08540.
  • Tager AM; Biofrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80302.
  • Seidman JG; Biofrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80302.
  • Ho CY; Biofrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80302.
Proc Natl Acad Sci U S A ; 119(28): e2204174119, 2022 07 12.
Article en En | MEDLINE | ID: mdl-35787042

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Receptores del Ácido Lisofosfatídico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Receptores del Ácido Lisofosfatídico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article